The burden of treatment in people living with type 2 diabetes: A qualitative study of patients and their primary care clinicians

Abstract

Background The burden of treatment can overwhelm people living with type 2 diabetes and lead to poor treatment fidelity and outcomes. Chronic care programs must consider and mitigate the burden of treatment while supporting patients in achieving their goals. Objective To explore what patients with type 2 diabetes and their health providers consider are the workload and the resources they must mobilize, i.e., their capacity, to shoulder it. Methods We conducted focus groups comprised of 30 patients and 32 clinicians from three community health centers in Chile implementing the Chronic Care Model to reduce cardiovascular risk in patients with type 2 diabetes. Transcripts were analyzed using thematic content analysis techniques illuminated by the Minimally Disruptive Medicine framework. Findings Gaining access to and working with their clinicians, implementing complex medication regimens, and changing lifestyles burdened patients. To deal with the distress of the diagnosis, difficulties achieving disease control, and fear of complications, patients drew capacity from their family (mostly men), social environment (mostly women), lay expertise, and spirituality. Clinicians found that administrative tasks, limited formulary, and protocol rigidity hindered their ability to modify care plans to reduce patient workload and support their capacity. Conclusions Chronic primary care programs burden patients living with type 2 diabetes while hindering clinicians’ ability to reduce treatment workloads or support patient capacity. A collaborative approach toward Minimally Disruptive Medicine may result in treatments that fit the lives and loves of patients and improve outcomes.

Effectiveness of Remotely Delivered Interventions to Simultaneously Optimize Management of Hypertension, Hyperglycemia and Dyslipidemia in People With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

“…The medical management of people with diabetes usually involves frequent face-to-face appointments with multiple specialists ( 11 ). This can contribute to confusion about how intensively risk factors should be controlled and who is responsible for managing these risk factors ( 12 ). It also disadvantages patients in rural and remote settings who may not be able to access specialist medical services easily ( 13 ).…”

Metformin, empagliflozin and their combination modulate ex-vivo macrophage inflammatory gene expression

“…Typically, patients may be prescribed with a single drug or combination of drugs depending on the severity of their disease (American Diabetes Association 2019, American Diabetes Association 2018) in accordance with health research association guidelines such as the National Institute of Health Care Excellence (NICE) or American Diabetic Association (ADA). This approach imparts an increasing therapeutic burden on the patient - either in the form of dosage upregulation or additional medications (Chaplin et al 2016, Espinoza et al 2020).…”

“…These agents may reduce insulin resistance, increase insulin secretion and glucose absorption from blood (Chaudhury et al 2017, Rakel et al 2018). However, many of these agents may worsen the co-morbid metabolic disorders in T2DM patients (Maggi et al 2019, Espinoza et al 2020, Chaudhury et al 2017, Rakel et al 2018). For example, Thiazolidinediones are potent anti-hyperglycemic agents, yet have been associated with worsening of CVD and related mortality (Waller et al 2018).…”

Multimorbidity and its effect on perceived burden, capacity and the ability to self-manage in a low-income rural primary care population: A qualitative study

“…The cumulative complexity model has been explored in a range of populations, including people with diabetes [ 29 ], kidney disease [ 30 ], stroke [ 31 ] and in low-middle income countries [ 32 ]. We wished to apply this model to a rural low-income multimorbid population, who were at risk of both high burden (from multiple health conditions) and low capacity (from resource constraints).…”